by James Lyons-Weiler, PhD, Popular Rationalism, ©2026
(May 23, 2026) — On March 20, 2026, the U.S. Attorney’s Office for the Northern District of California announced that Anar Rustamov, a 38-year-old Azerbaijani national formerly of Sunnyvale, California, had been charged in connection with a scheme that allegedly used an entity he created, Dublin Helping Hand, to submit thousands of fraudulent durable medical equipment claims to Medicare Advantage Organizations between October 2024 and June 2025, seeking more than $90 million for blood glucose monitors, orthotic braces, and related equipment that was allegedly not provided, not medically necessary, and not authorized by a medical provider.
DOJ also stated that the listed beneficiaries were unaware of the claims, that the referring provider listed on the submissions had not authorized them, and that Rustamov was at large as of the announcement. HHS-OIG simultaneously published a parallel enforcement page confirming the action. [1]
The case matters beyond its dollar figure because it appears to target a claims-side fraud vector in Medicare Advantage, not the better-known risk-adjustment coding cases that have dominated recent Medicare Advantage enforcement. In other words, the public allegations are not that a Medicare Advantage plan inflated diagnosis codes to obtain higher CMS capitated payments; they are that a purported DME supplier submitted false claims to the plans themselves on behalf of unsuspecting beneficiaries. That distinction is central. It places the alleged failure point inside the fragmented anti-fraud environment of Medicare Part C plan operations and DME supplier controls, rather than the traditional Medicare fee-for-service MAC environment or the civil risk-adjustment arena. [2]
Publicly accessible materials remain materially incomplete. I was able to verify the DOJ press release, the HHS-OIG enforcement page, and several reputable reports repeating or lightly elaborating on those allegations. I was not able to verify a public indictment PDF, a case-specific PACER/CM-ECF docket URL, an unsealed docket sheet, exact statutory counts beyond what secondary reports described, an arrest or extradition update, any seizure amount, any restitution demand, or any plan-specific payment/recovery figure. Because of those gaps, this report distinguishes sharply between verified facts, high-confidence inferences, and unknowns. [3]
The strongest analytic conclusion is straightforward: the allegations describe a classic DME fraud architecture adapted to the Medicare Advantage environment—front entity creation, unauthorized use of beneficiary identity, unauthorized use of referring-provider information, high-volume claim submission, and exploitation of fragmented plan-level controls. What the public record does not yet show is equally important: named co-conspirators, billing companies, clearinghouses, telemarketers, sham telemedicine vendors, specific HCPCS codes, bank accounts, laundering routes, or actual paid loss. Those omissions limit precision, but they do not erase the structural lesson. [4]
Read the rest here.